The Effect of Simvastatin on Infection-Induced Inflammatory Response of Human Fetal Membranes

American Journal of Reproductive Immunology

Volumn 74, Issue 1, 2015, Pages 54-61

  Basraon, Sanmaan K ^a   Costantine, Maged M ^a   Saade, George ^a   Menon, Ramkumar ^a  

^a University of Texas Medical Branch School of Medicine   (United States)

Author keywords

Cytokines; Matrix metalloproteinases; Pregnancy; Preterm birth; Preterm labor

Indexed keywords

GELATINASE A; GELATINASE B; INTERLEUKIN 10; INTERLEUKIN 1BETA; INTERLEUKIN 6; INTERSTITIAL COLLAGENASE; LIPOPOLYSACCHARIDE; MATRILYSIN; SIMVASTATIN; STROMELYSIN 2; TISSUE INHIBITOR OF METALLOPROTEINASE 2; TUMOR NECROSIS FACTOR ALPHA; CYTOKINE; CYTOKINE RECEPTOR; TIMP2 PROTEIN, HUMAN;

ANTIINFLAMMATORY ACTIVITY; ARTICLE; BIOAVAILABILITY; CHORION; COMPETITIVE INHIBITION; CONTROLLED STUDY; CYTOKINE PRODUCTION; DOWN REGULATION; FETUS MEMBRANE; HOMEOSTASIS; HUMAN; HUMAN TISSUE; IMMUNOREACTIVITY; LABOR ONSET; PLACENTA; PREMATURE LABOR; PRIORITY JOURNAL; CYTOLOGY; EMBRYO CULTURE; EMBRYO MEMBRANE; FEMALE; FETUS; IMMUNOLOGY; INFLAMMATION; METABOLISM; MICROBIOLOGY; PREGNANCY;

CYTOKINES; EMBRYO CULTURE TECHNIQUES; EXTRAEMBRYONIC MEMBRANES; FEMALE; FETUS; HUMANS; INFLAMMATION; LIPOPOLYSACCHARIDES; PREGNANCY; RECEPTORS, CYTOKINE; SIMVASTATIN; TISSUE INHIBITOR OF METALLOPROTEINASE-2;

EID: 84931563011     PISSN: 10467408     EISSN: 16000897     Source Type: Journal    
DOI: 10.1111/aji.12372     Document Type: Article

References (23)

1. Martin JA, Hamilton BE, Ventura SJ, Osterman MJ, Kirmeyer S, Mathews TJ, Wilson EC: Births: final data for 2009. Natl Vital Stat Rep 2011; 60:1-70.
2. St John EB, Nelson KG, Cliver SP, Bishnoi RR, Goldenberg RL: Cost of neonatal care according to gestational age at birth and survival status. Am J Obstet Gynecol 2000; 182:170-175.
3. Beck S, Wojdyla D, Say L, Betran AP, Merialdi M, Requejo JH, Rubens C, Menon R, Van Look PF: The worldwide incidence of preterm birth: a systematic review of maternal mortality and morbidity. Bull World Health Organ 2010; 8:31-38.
4. Goldenberg RL, Culhane JF, Iams JD, Romero R: Epidemiology and causes of preterm birth. Lancet 2008; 371:75-84.
5. Romero R, Espinoza J, Kusanovic JP, Gotsch F, Hassan S, Erez O, Chaiworapongsa T, Mazor M: The preterm parturition syndrome. BJOG 2006; 113(Suppl. 3):17-42.
6. Fortunato SJ, Menon RP, Swan KF, Menon R: Inflammatory cytokine (interleukins 1, 6 and 8 and tumor necrosis factor-alpha) release from cultured human fetal membranes in response to endotoxic lipopolysaccharide mirrors amniotic fluid concentrations. Am J Obstet Gynecol 1996; 174:1855-1861 discussion 1861-1852.
7. Moss TJ: Respiratory consequences of preterm birth. Clin Exp Pharmacol Physiol 2006; 33:280-284.
8. Elovitz MA, Brown AG, Breen K, Anton L, Maubert M, Burd I: Intrauterine inflammation, insufficient to induce parturition, still evokes fetal and neonatal brain injury. Int J Dev Neurosci 2011; 29:663-671.
9. Haas DM, Caldwell DM, Kirkpatrick P, McIntosh JJ, Welton NJ: Tocolytic therapy for preterm delivery: systematic review and network meta-analysis. BMJ 2012; 345:e6226.
10. Kolovou GD, Katerina A, Ioannis V, Cokkinos DV: Simvastatin: two decades in a circle. Cardiovasc Ther 2008; 26:166-178.
11. Kanda H, Hamasaki K, Kubo K, Tateishi S, Yonezumi A, Kanda Y, Yamamoto K, Mimura T: Antiinflammatory effect of simvastatin in patients with rheumatoid arthritis. J Rheumatol 2002; 29:2024-2026.
12. McKay A, Leung BP, McInnes IB, Thomson NC, Liew FY: A novel anti-inflammatory role of simvastatin in a murine model of allergic asthma. J Immunol 2004; 172:2903-2908.
13. Montaner J: Treatment with statins in the acute phase of ischemic stroke. Expert Rev Neurother 2005; 5:211-221.
14. Rabadi MH, Blass J: Randomized clinical stroke trials in 2004. Curr Atheroscler Rep 2005; 7:319-325.
15. Basraon SK, Menon R, Makhlouf M, Longo M, Hankins GD, Saade GR, Costantine MM: Can statins reduce the inflammatory response associated with preterm birth in an animal model? Am J Obstet Gynecol 2012; 207:224.e1-7.
16. Fortunato SJ, Menon R, Swan KF, Lyden TW: Organ culture of amniochorionic membrane in vitro. Am J Reprod Immunol 1994; 32:184-187.
17. Lilja JJ, Kivisto KT, Neuvonen PJ: Grapefruit juice-simvastatin interaction: effect on serum concentrations of simvastatin, simvastatin acid, and HMG-CoA reductase inhibitors. Clin Pharmacol Ther 1998; 64:477-483.
18. Sadowsky DW, Adams KM, Gravett MG, Witkin SS, Novy MJ: Preterm labor is induced by intraamniotic infusions of interleukin-1beta and tumor necrosis factor-alpha but not by interleukin-6 or interleukin-8 in a nonhuman primate model. Am J Obstet Gynecol 2006; 195:1578-1589.
19. Menon R, Torloni MR, Voltolini C, Torricelli M, Merialdi M, Betrán AP, Widmer M, Allen T, Davydova I, Khodjaeva Z, Thorsen P, Kacerovsky M, Tambor V, Massinen T, Nace J, Arora C: Biomarkers of spontaneous preterm birth: an overview of the literature in the last four decades. Reprod Sci 2011; 18:1046-1070.
20. Menon R, Fortunato SJ: The role of matrix degrading enzymes and apoptosis in rupture of membranes. J Soc Gynecol Investig 2004; 11:427-437.
21. Dichtl W, Dulak J, Frick M, Alber HF, Schwarzacher SP, Ares MP, Nilsson J, Pachinger O, Weidinger F: HMG-CoA reductase inhibitors regulate inflammatory transcription factors in human endothelial and vascular smooth muscle cells. Arterioscler Thromb Vasc Biol 2003; 23:58-63.
22. Kusters DM, Hassani Lahsinoui H, devan Post JA, Wiegman A, Wijburg FA, Kastelein JJ, Hutten BA: Statin use during pregnancy: a systematic review and meta-analysis. Expert Rev Cardiovasc Ther 2012; 10:363-378.
23. Manson JM, Freyssinges C, Ducrocq MB, Stephenson WP: Postmarketing surveillance of lovastatin and simvastatin exposure during pregnancy. Reprod Toxicol 1996; 10:439-446.